BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 6372846)

  • 21. Long term trial of ketotifen in bronchial asthma.
    Podleski WK; Zelenak TM; Schmidt JL
    Ann Allergy; 1984 Jun; 52(6):406-10. PubMed ID: 6428279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Administration of half-dose theophylline together with ketotifen to asthmatic children--a double-blind, placebo-controlled study.
    Volovitz B; Amir J; Malik H; Lerman M; Varsano I
    J Asthma; 1994; 31(1):27-34. PubMed ID: 8175622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plant-based formulation for bronchial asthma: a controlled clinical trial to compare its efficacy with oral salbutamol and theophylline.
    Murali PM; Rajasekaran S; Krishnarajasekar OR; Perumal T; Nalini K; Lakshmisubramanian S; Deivanayagam CN
    Respiration; 2006; 73(4):457-63. PubMed ID: 16308544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Asthma and nifedipine. Comparison of nifedipine, ketotifen and placebo in the prophylaxis of childhood extrinsic asthma.
    Montoya F
    Allergol Immunopathol (Madr); 1988; 16(4):253-8. PubMed ID: 3067566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Symptoms and peak expiratory flow rate: response to a slow release theophylline preparation.
    Ho TF; Ngiam TE; Koh PK
    Singapore Med J; 1983 Oct; 24(5):280-4. PubMed ID: 6669991
    [No Abstract]   [Full Text] [Related]  

  • 26. [Ketotifen in the prevention of bronchial asthma. International therapeutic evaluation].
    Craps L
    Allergol Immunopathol (Madr); 1981; Suppl 9():177-90. PubMed ID: 6131598
    [No Abstract]   [Full Text] [Related]  

  • 27. A multicenter trial of the prophylactic effect of ketotifen, theophylline, and placebo in atopic asthma.
    Tinkelman DG; Moss BA; Bukantz SC; Sheffer AL; Dobken JH; Chodosh S; Cohen BM; Rosenthal RR; Rappaport I; Buckley CE
    J Allergy Clin Immunol; 1985 Sep; 76(3):487-97. PubMed ID: 3897345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy of ketotifen in a controlled double-blind food challenge study in patients with food allergy.
    Boner AL; Richelli C; Antolini I; Vibelli C; Andri L
    Ann Allergy; 1986 Jul; 57(1):61-4. PubMed ID: 3524320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multicenter study with ketotifen (Zaditen).
    Burns RB
    N Engl Reg Allergy Proc; 1985; 6(1):78-83. PubMed ID: 3939673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controlled-release theophylline and proxyphylline in asthmatics: a comparative study.
    Mosbech H; Paulsen H; Søborg M
    Pharmatherapeutica; 1984; 3(9):626-30. PubMed ID: 6374684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical studies on the protective effects of Ketotifen and Intal in atopic asthmatic patients.
    Románski B; Pawlik-Miskiewicz K; Wilewska-Klubo T
    Allergol Immunopathol (Madr); 1983; 11(1):34-9. PubMed ID: 6407291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ketotifen in the prophylaxis of extrinsic bronchial asthma. A multicenter controlled double-blind study with a modified-release formulation.
    Medici TC; Radielovic P; Morley J
    Chest; 1989 Dec; 96(6):1252-7. PubMed ID: 2684551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Ketotifen, a new prophylactic agent in asthma (author's transl)].
    Giesen HK; Fryda-Kaurimsky Z
    Med Klin; 1979 Oct; 74(42):1553-6. PubMed ID: 231737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of chronic asthma in children with a sustained-release preparation of theophylline in addition to beta 2-stimulating agents.
    Lönnerholm G; Foucard T; Lindström B
    Eur J Respir Dis Suppl; 1980; 109():95-7. PubMed ID: 6108230
    [No Abstract]   [Full Text] [Related]  

  • 35. A double blind placebo controlled study on the use of ketotifen in childhood asthma.
    Mulhern B; O'Connor N; Hillery M; Ward OC
    Ir Med J; 1982 Jan; 75(1):25-8. PubMed ID: 7085236
    [No Abstract]   [Full Text] [Related]  

  • 36. A Canadian multicenter study with Zaditen (ketotifen) in the treatment of bronchial asthma in children aged 5 to 17 years.
    Rackham A; Brown CA; Chandra RK; Ho P; Hoogerwerf PE; Kennedy RJ; Knight A; Langer H; Milne J; Moote DW
    J Allergy Clin Immunol; 1989 Sep; 84(3):286-96. PubMed ID: 2674262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metaproterenol sulfate for asthmatic children with therapeutic serum theophylline concentrations.
    Kelly HW; Menendez R; Murphy S; Tuttle W
    Clin Pharm; 1982; 1(1):49-54. PubMed ID: 6764162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical evaluation of a new orally active anti-anaphylactic compound: ketotifen (HC 20-511) in Japanese adult asthmatics.
    Kumagai A; Tomioka H; Shida T; Takahashi T; Muranaka M
    Schweiz Med Wochenschr; 1980 Feb; 110(6):197-203. PubMed ID: 6769159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Slow release theophylline in preschool asthmatics.
    Conway SP; Houlsby WT
    Arch Dis Child; 1986 Oct; 61(10):1024-6. PubMed ID: 3535686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of ketotifen in young children with asthma.
    Volovitz B; Varsano I; Cumella JC; Jaber L
    J Allergy Clin Immunol; 1988 Mar; 81(3):526-30. PubMed ID: 3279095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.